Patent · US Active

Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof

US10940117B2 · kind B2 · utility

0Cited by

42References

12Claims

0Family size

Assignee

ARBOR PHARMACEUTICALS, LLC · US

Inventors

Sami Karaborni · Cupertino, US
Sarina Grace Harris Ma · Santa Clara, US
Chen Mao · Shanghai, CN
Ching Wah Chong · Fremont, US
Peter Robert Prinz Freed · Linglestown, US
Mesut Ciper · Oelde, DE
Stefanie Krenzlin · Munster, DE
David Juergen Wustrow · Ann Arbor, US
Peter A. Virsik · Portola Valley, US

Key dates

Filing date	Apr 20, 2020
Grant date	Mar 9, 2021
Priority date	—
Expiry date	Apr 20, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Improved oral dosage forms of methyl hydrogen fumarate and prodrugs thereof are disclosed. Methods of treating diseases such as multiple sclerosis and psoriasis using such dosage forms are also disclose.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.